Pimentel A M L, Costa C A, Carvalho L C R M, Brandão R M, Rangel B M, Tano T, Soares de Moura R, Resende A C
Departamento de Farmacologia e Psicobiologia, Instituto de Biologia, Centro Biomédico, Universidade do Estado do Rio de Janeiro, Av. 28 de Setembro 87, Rio de Janeiro, Brazil.
Vascul Pharmacol. 2007 May;46(5):353-9. doi: 10.1016/j.vph.2006.12.003. Epub 2006 Dec 20.
The mechanisms involved in the vasodilation action of clonidine have not yet been completely elucidated. We investigated the potential mechanisms that seem to be involved in the clonidine vasodilator effect using rat isolated mesenteric arterial bed (MAB). In precontracted MAB, clonidine (10-300 pmol) induced a dose-dependent relaxation, that was inhibited by endothelium removal (deoxycholic acid - 2.5 mM) and reduced by the alpha(2) adrenoceptor inhibitors yohimbine (1-3 microM) and rauwolscine (1 microM). The endothelium-dependent vasodilation induced by clonidine was reduced by the nitric oxide (NO) synthase inhibitor L-NAME (0.3 mM) and guanylyl cyclase inhibitor ODQ (10 microM) but was not affected by indomethacin (3-10 microM) alone. High K+ (25 mM) solution reduced the vasodilator effect of clonidine that was further attenuated by L-NAME. In the presence of high K+ plus L-NAME, the residual vasodilator effect of clonidine was further reduced by indomethacin (3 microM). The Ca(2+)-dependent K+ channel (K+(Ca2+)) inhibitors, charybdotoxin (ChTx; 0.1 microM) plus apamin (0.1 microM), also reduced the vasodilation induced by clonidine, however this response was not further reduced in the presence of L-NAME as observed with acetylcholine (10 pmol). In the presence of ATP-dependent K+ channel (K+(ATP)) blocker, glibenclamide (10 microM), the inhibitory effect of ChTx plus apamin plus L-NAME was increased. In contrast, the vasodilation induced by clonidine was not affected by voltage-dependent K+ channels (K(V)) blocker, 4-aminopyridine (4-AP, 1 mM). In conclusion, our results demonstrate that clonidine activates alpha(2)-adrenoceptors in rat MAB and that the endothelium-dependent vasodilation is mediated by activation of NO-cGMP pathway, hyperpolarization due to activation of K+(Ca) and K+(ATP) channels. Prostaglandins might participate in the vasodilator effect of clonidine when NO and EDHF mechanisms are blunted.
可乐定血管舒张作用所涉及的机制尚未完全阐明。我们使用大鼠离体肠系膜动脉床(MAB)研究了似乎与可乐定血管舒张作用相关的潜在机制。在预收缩的MAB中,可乐定(10 - 300 pmol)诱导剂量依赖性舒张,这种舒张被去除内皮(脱氧胆酸 - 2.5 mM)所抑制,并被α(2)肾上腺素能受体抑制剂育亨宾(1 - 3 microM)和雷伏辛(1 microM)减弱。可乐定诱导的内皮依赖性血管舒张被一氧化氮(NO)合酶抑制剂L - NAME(0.3 mM)和鸟苷酸环化酶抑制剂ODQ(10 microM)减弱,但单独使用吲哚美辛(3 - 10 microM)对其无影响。高钾(25 mM)溶液减弱了可乐定的血管舒张作用,L - NAME使其进一步减弱。在高钾加L - NAME存在的情况下,可乐定残留的血管舒张作用被吲哚美辛(3 microM)进一步减弱。钙依赖性钾通道(K+(Ca2+))抑制剂,蝎毒素(ChTx;0.1 microM)加蜂毒明肽(0.1 microM),也减弱了可乐定诱导的血管舒张,然而与乙酰胆碱(10 pmol)不同,在L - NAME存在的情况下,这种反应并未进一步减弱。在存在ATP依赖性钾通道(K+(ATP))阻滞剂格列本脲(10 microM)的情况下,ChTx加蜂毒明肽加L - NAME的抑制作用增强。相反,可乐定诱导的血管舒张不受电压依赖性钾通道(K(V))阻滞剂4 - 氨基吡啶(4 - AP,1 mM)的影响。总之,我们的结果表明,可乐定激活大鼠MAB中的α(2) - 肾上腺素能受体,内皮依赖性血管舒张是由NO - cGMP途径的激活、K+(Ca)和K+(ATP)通道的激活导致的超极化介导的。当NO和内皮依赖性超极化因子(EDHF)机制减弱时,前列腺素可能参与可乐定的血管舒张作用。